Oramed Pharmaceuticals (ORMP) EBT (2011 - 2026)
Oramed Pharmaceuticals (ORMP) posted EBT of $49.4 million for Q1 2026, up 404.64% on a QoQ basis from $9.8 million in Q4 2025, and up 800.48% year-over-year from $5.5 million in Q1 2025.
Oramed Pharmaceuticals (ORMP) EBT (2011 - 2026) Analysis & Trends
Oramed Pharmaceuticals' EBT history runs 15 years deep, the most recent figure standing at $49.4 million for Q1 2026.
- Quarterly EBT rose 800.48% year-over-year to $49.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $131.8 million (up 637.79% YoY) and the FY2025 annual result came in at $75.3 million, up 573.14% from the prior year.
- EBT was $49.4 million for Q1 2026 at Oramed Pharmaceuticals, up from $9.8 million in the prior quarter.
- Across five years, EBT topped out at $59.5 million in Q3 2025 and bottomed at -$18.5 million in Q3 2024.
- A 5-year average of $4.2 million and a median of -$3.3 million in 2023 frame the typical range for EBT.
- Annual changes were most pronounced in 2024 — EBT jumped 925.44% — and 2025, when it slumped 560.1%.
- Oramed Pharmaceuticals' EBT stood at -$12.3 million in 2022, then jumped by 208.49% to $13.3 million in 2023, then tumbled by 173.58% to -$9.8 million in 2024, then jumped by 200.14% to $9.8 million in 2025, then jumped by 404.64% to $49.4 million in 2026.
- Business Quant data shows ORMP's EBT at $49.4 million in Q1 2026, $9.8 million in Q4 2025, and $59.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -36.97 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 259.22 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -3.49 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.25 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 831.20 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | -26.94 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 541.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -453.82 Mn |
| 10 | Oramed Pharmaceuticals | 170.25 Mn | 170.25 Mn | - | 49.44 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 49.44 Mn |
| Dec 31, 2025 | 9.80 Mn |
| Sep 30, 2025 | 59.45 Mn |
| Jun 30, 2025 | 13.13 Mn |
| Mar 31, 2025 | -7.06 Mn |
| Dec 31, 2024 | -9.78 Mn |
| Sep 30, 2024 | -18.51 Mn |
| Jun 30, 2024 | 10.84 Mn |
| Mar 31, 2024 | 1.53 Mn |
| Dec 31, 2023 | 13.30 Mn |
| Sep 30, 2023 | -3.28 Mn |
| Jun 30, 2023 | -1.31 Mn |
| Mar 31, 2023 | -3.62 Mn |
| Dec 31, 2022 | -12.26 Mn |
| Sep 30, 2022 | -7.15 Mn |
| Jun 30, 2022 | -12.10 Mn |
| Mar 31, 2022 | -11.65 Mn |
| Aug 31, 2021 | -22.99 Mn |
| Nov 30, 2019 | -2.45 Mn |
| Aug 31, 2019 | 25.83 Mn |